JPRN-jRCTs051200147已完成4 期
Effect of empagliflozin on urinary albumin excretion and hypoxic injury biomarkers of early phase diabetic kidney disease - EUROBEAT Study
Makino Hisashi0 个研究点目标入组 80 人开始时间: 2021年3月5日最近更新:
适应症
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 发起方
- 入组人数
- 80
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 < 85age old（—）
- 性别
- All
入选标准
- •20 years old or older, less than 85 years old with type 2 diabetes mellitus HbA1c of 6.5% or higher, and less than 10.0%
- •Urinary albumin excretion of 30mg/gCr or higher, and less than 300mg/gCr, and eGFR more than 30ml/min/1.72m2
- •No change in internal use of renin-angiotensin system inhibitors within 3 months of consent
- •No change in internal use of hypoglycemic drugs within 3 months of consent
排除标准
- •BMI less than 18.5 kg/m2
- •Patients who diagnosed as chronic glomerulonephritis
- •Patients who are /want to pregnant, or are breast feeding
- •Patients taking SGLT2 inhibitors within 3 months of consent
- •Patients with heart failure of NYHA III or IV New York Heart Association functional classification
- •Patients who diagnosed as acute coronary syndrome or stroke within 3 months of consent
- •Patients who performed PCI or CABG within 3 months of consent
研究者
相似试验
已完成
不适用
Effect of canagliflozin on urinary albumin excretion in type 2 diabetic patients with microalbuminuria (pilot study)Type 2 diabetic patients with microalbuminuriaJPRN-UMIN000023959akakinen clinic Medical Corporation Kensei-kai20
已完成
1 期
Effect of empagliflozin/linagliptin on albuminuria and urinary liver-type free fatty acid binding protein in type 2 diabetic patients with chronic kidney disease: A randomized controlled trialT2DM and CKD patients with albuminuriaTCTR20210317005/A48
招募中
4 期
Effect of Tofogliflozin on Urine Albumin-to-Creatinine Ratio Compared to Metformin Hydrochloride in Diabetic Kidney DiseaseJPRN-jRCTs031210339Kuwahara Koichiro120
进行中（未招募）
1 期
Effects of empagliflozin on urine output and renal function in patients with acute heart failureMedDRA version: 20.0Level: LLTClassification code 10000803Term: Acute heart failureSystem Organ Class: 100000004849acute decompensated heart failureEUCTR2018-003692-35-DEFriedrich Schiller University Jena60
已完成
不适用
The effect of empagliflozin on diuresis and neurohumoral factors in the patients with decompensated heart failure and diabetes mellitus: pilot studydecompensated heaat failure type 2 diabetes mellitusJPRN-UMIN000027431Department of Cardiology, National Hospital Organization Yokohama Medical Center15